title: High-frequency MRI monitoring should be performed in natalizumab-treated MS patients with higher risk of PML - NO.
authors.affiliation: Division of General Neurology, University Clinic of Neurology, Medical University of Graz, Graz, Austria/Division of Neuroradiology, Vascular and Interventional Radiology, University Clinic of Radiology, Medical University of Graz, Graz, Austria.
authors.forename: Christian
authors.initials: C
authors.lastname: Enzinger
mesh_terms: D000328:Adult; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000000981:diagnostic imaging* / Q000209:etiology; D008279:Magnetic Resonance Imaging / Q000592:standards*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab / Q000009:adverse effects*
chemical_list: D007155:Immunologic Factors; D000069442:Natalizumab